NMD Pharma, finalist i Life Sciences kategorien - EY Danmark
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis | MENAFN.COM
Big deal: NMD flexes series A muscles - Global University Venturing
Investors — NMD Pharma
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma
NMD Pharma company information, funding & investors | Dealroom.co
Roel Bulthuis - Director at NMD Pharma | The Org
NMD Pharma raises $47M in series A investment round from INKEF and existing investors, to advance treatments of neuromuscular disorders | Nordic 9
Nete Huus's email & phone | NMD Pharma ApS's Senior Scientist email
NMD Pharma A/S | LinkedIn
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma - Inkef capital
Neuromuscular Drug Development Summit (NMD) - Pharma Journalist
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
Erhverv Aarhus - 照片| Facebook
NMD Pharma - PIR International
NMD Pharma A/S | LinkedIn
Detailed Description | NMD-GPS
Klaus Wilhardt - Corporate identity, Design, Logo/navnetræk og designguides
Prominent Canadian researcher in Denmark: Why I left a top job in California
